{"id":8555,"date":"2020-07-29T10:59:26","date_gmt":"2020-07-29T17:59:26","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=8555"},"modified":"2021-04-05T11:00:10","modified_gmt":"2021-04-05T18:00:10","slug":"30-day-mortality-and-morbidity-in-covid-19-versus-influenza-a-population-based-study","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/07\/29\/30-day-mortality-and-morbidity-in-covid-19-versus-influenza-a-population-based-study\/","title":{"rendered":"30-Day Mortality and Morbidity in COVID-19 versus Influenza A Population-based Study"},"content":{"rendered":"<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"34\" data-aria-posinset=\"2019\" data-aria-level=\"1\"><i><span data-contrast=\"none\">[pre-print, not peer-reviewed]<\/span><\/i><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">In an analysis u<\/span><span data-contrast=\"auto\">sing<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">population-based\u00a0<\/span><span data-contrast=\"auto\">data from Denmark (November 1, 2017 to June 30, 2020),\u00a0<\/span><span data-contrast=\"auto\">among in<\/span><span data-contrast=\"auto\">patients<\/span><span data-contrast=\"auto\">, those\u00a0<\/span><span data-contrast=\"auto\">who\u00a0<\/span><span data-contrast=\"auto\">tested positive for SARS-CoV-2 (<\/span><span data-contrast=\"auto\">n=<\/span><span data-contrast=\"auto\">1<\/span><span data-contrast=\"auto\">,<\/span><span data-contrast=\"auto\">657<\/span><span data-contrast=\"auto\">)\u00a0<\/span><span data-contrast=\"auto\">had a 30-day mortality of 21% compared to 7% among those who tested positive for influenza (n=7,200). Among outpatients, the 30-day mortality was 2% among those positive for SARS-CoV-2\u00a0<\/span><span data-contrast=\"auto\">(n=6,263)\u00a0<\/span><span data-contrast=\"auto\">and 0.4% among those positive for<\/span><span data-contrast=\"auto\">\u00a0influenza<\/span><span data-contrast=\"auto\">\u00a0(n=7,204)<\/span><span data-contrast=\"auto\">.\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span data-contrast=\"none\">Nersesjan\u00a0et al. (July 28, 2020). 30-Day Mortality and Morbidity in COVID-19 versus Influenza A Population<\/span><\/i><i><span data-contrast=\"none\">&#8211;<\/span><\/i><i><span data-contrast=\"none\">based Study. Pre-print\u00a0downloaded July 29 from\u00a0<\/span><\/i><a href=\"https:\/\/doi.org\/10.1101\/2020.07.25.20162156\"><span data-contrast=\"none\">https:\/\/doi.org\/10.1101\/2020.07.25.20162156<\/span><\/a><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559685&quot;:720,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[pre-print, not peer-reviewed]\u00a0In an analysis using\u00a0population-based\u00a0data from Denmark (November 1, 2017 to June 30, 2020),\u00a0among inpatients, those\u00a0who\u00a0tested positive for SARS-CoV-2 (n=1,657)\u00a0had a 30-day mortality of 21% compared to 7% among those who tested positive for influenza (n=7,200). Among outpatients, the 30-day mortality was 2% among those positive for SARS-CoV-2\u00a0(n=6,263)\u00a0and 0.4% among those positive for\u00a0influenza\u00a0(n=7,204).\u00a0\u00a0 Nersesjan\u00a0et&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/07\/29\/30-day-mortality-and-morbidity-in-covid-19-versus-influenza-a-population-based-study\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"topic":[20],"class_list":["post-8555","post","type-post","status-publish","format-standard","hentry","category-article-summary","topic-clinical-characteristics-and-health-care-setting"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8555","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=8555"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8555\/revisions"}],"predecessor-version":[{"id":8556,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8555\/revisions\/8556"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=8555"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=8555"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=8555"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=8555"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}